NO331027B1 - Forbindelse som bindes til en mpl-reseptor, dimer, polynukleotid, vektor, vertscelle, fremgangsmate for fremstilling av en forbindelse, anvendelse av en forbindelse for fremstilling av et medikament, samt farmasoytisk preparat. - Google Patents
Forbindelse som bindes til en mpl-reseptor, dimer, polynukleotid, vektor, vertscelle, fremgangsmate for fremstilling av en forbindelse, anvendelse av en forbindelse for fremstilling av et medikament, samt farmasoytisk preparat.Info
- Publication number
- NO331027B1 NO331027B1 NO20011962A NO20011962A NO331027B1 NO 331027 B1 NO331027 B1 NO 331027B1 NO 20011962 A NO20011962 A NO 20011962A NO 20011962 A NO20011962 A NO 20011962A NO 331027 B1 NO331027 B1 NO 331027B1
- Authority
- NO
- Norway
- Prior art keywords
- compound
- preparation
- dimer
- polynucleotide
- binds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 3
- 239000000539 dimer Substances 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000040430 polynucleotide Human genes 0.000 title 1
- 108091033319 polynucleotide Proteins 0.000 title 1
- 239000002157 polynucleotide Substances 0.000 title 1
- 239000013598 vector Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/524—Thrombopoietin, i.e. C-MPL ligand
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10534898P | 1998-10-23 | 1998-10-23 | |
PCT/US1999/024834 WO2000024770A2 (en) | 1998-10-23 | 1999-10-22 | Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20011962D0 NO20011962D0 (no) | 2001-04-20 |
NO20011962L NO20011962L (no) | 2001-06-21 |
NO331027B1 true NO331027B1 (no) | 2011-09-12 |
Family
ID=22305310
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20011962A NO331027B1 (no) | 1998-10-23 | 2001-04-20 | Forbindelse som bindes til en mpl-reseptor, dimer, polynukleotid, vektor, vertscelle, fremgangsmate for fremstilling av en forbindelse, anvendelse av en forbindelse for fremstilling av et medikament, samt farmasoytisk preparat. |
NO2012005C NO2012005I2 (no) | 1998-10-23 | 2012-03-12 | Romiplostim |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO2012005C NO2012005I2 (no) | 1998-10-23 | 2012-03-12 | Romiplostim |
Country Status (36)
Country | Link |
---|---|
US (8) | US6835809B1 (pl) |
EP (3) | EP2319928B9 (pl) |
JP (2) | JP3820105B2 (pl) |
KR (1) | KR100719202B1 (pl) |
CN (2) | CN1250721C (pl) |
AR (1) | AR020934A1 (pl) |
AT (1) | ATE348163T1 (pl) |
AU (1) | AU773891C (pl) |
BG (3) | BG110221A (pl) |
BR (1) | BRPI9914698B8 (pl) |
CA (1) | CA2346996C (pl) |
CY (4) | CY1107526T1 (pl) |
CZ (1) | CZ302155B6 (pl) |
DE (2) | DE69934425T2 (pl) |
DK (3) | DK1124961T3 (pl) |
EA (1) | EA003998B1 (pl) |
ES (3) | ES2279649T3 (pl) |
FR (1) | FR09C0030I2 (pl) |
HK (2) | HK1042114B (pl) |
HU (1) | HU228582B1 (pl) |
IL (1) | IL142023A0 (pl) |
LT (1) | LTC1124961I2 (pl) |
LU (1) | LU91598I2 (pl) |
ME (2) | MEP42108A (pl) |
MY (1) | MY126795A (pl) |
NL (1) | NL300398I2 (pl) |
NO (2) | NO331027B1 (pl) |
NZ (1) | NZ510529A (pl) |
PL (1) | PL219605B1 (pl) |
PT (3) | PT2319928E (pl) |
RS (1) | RS51237B (pl) |
SI (3) | SI2319928T1 (pl) |
SK (1) | SK287737B6 (pl) |
TW (2) | TWI250988B (pl) |
WO (1) | WO2000024770A2 (pl) |
ZA (1) | ZA200102102B (pl) |
Families Citing this family (148)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7091311B2 (en) * | 1996-06-07 | 2006-08-15 | Smithkline Beecham Corporation | Peptides and compounds that bind to a receptor |
MY126795A (en) | 1998-10-23 | 2006-10-31 | Amgen K A Inc | Dimeric thrombopoietic peptide mimetics binding to mp1 receptor and having thrombopoietic activity. |
US6808902B1 (en) * | 1999-11-12 | 2004-10-26 | Amgen Inc. | Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
EP1274730A2 (en) * | 2000-04-21 | 2003-01-15 | Amgen, Inc. | Integrin/adhesion antagonists |
US20020090646A1 (en) * | 2000-05-03 | 2002-07-11 | Amgen Inc. | Calcitonin-related molecules |
WO2001095942A2 (en) * | 2000-06-09 | 2001-12-20 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates |
ES2258558T3 (es) * | 2000-12-05 | 2006-09-01 | Alexion Pharmaceuticals, Inc. | Anticuerpos diseñados racionalmente. |
US7396917B2 (en) * | 2000-12-05 | 2008-07-08 | Alexion Pharmaceuticals, Inc. | Rationally designed antibodies |
US20040018203A1 (en) * | 2001-06-08 | 2004-01-29 | Ira Pastan | Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates |
CA2457164A1 (en) | 2001-08-17 | 2003-02-27 | Enkam Pharmaceuticals A/S | Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells |
US7332474B2 (en) | 2001-10-11 | 2008-02-19 | Amgen Inc. | Peptides and related compounds having thrombopoietic activity |
US20030191056A1 (en) | 2002-04-04 | 2003-10-09 | Kenneth Walker | Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins |
BR0314591A (pt) * | 2002-09-18 | 2005-08-09 | Ortho Mcneil Pharm Inc | Métodos de aumento de plaquetas e produção de célula tronco hematopoiética |
TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
PL1629007T3 (pl) | 2003-05-12 | 2009-09-30 | Affymax Inc | Nowe peptydy wiążące się z receptorem erytropoetyny |
EP1625156B1 (en) | 2003-05-12 | 2012-09-19 | Affymax, Inc. | Peptides that bind to the erythropoietin receptor |
EA010016B1 (ru) * | 2003-05-12 | 2008-06-30 | Афимакс, Инк. | Новые модифицированные полиэтиленгликолем соединения и их применение |
BRPI0411166A (pt) * | 2003-05-12 | 2006-07-18 | Affymax Inc | composto compreendendo uma parcela de peptìdeo, uma parcela espaçadora e uma parcela de polìmero solúvel em água e composição farmacêutica compreendendo tal composto |
MXPA06015234A (es) * | 2004-06-30 | 2007-11-22 | Nektar Therapeutics Al Corp | Conjugados de fraccion polimero-factor ix. |
EP1773400A2 (en) * | 2004-07-08 | 2007-04-18 | Amgen Inc. | Therapeutic peptides |
US7550433B2 (en) | 2005-06-03 | 2009-06-23 | Affymax, Inc. | Erythropoietin receptor peptide formulations and uses |
CA2648732A1 (en) * | 2005-06-23 | 2006-12-28 | Aplagen Gmbh | Supravalent compounds |
US8008453B2 (en) | 2005-08-12 | 2011-08-30 | Amgen Inc. | Modified Fc molecules |
WO2007075899A2 (en) * | 2005-12-21 | 2007-07-05 | Maxygen, Inc. | Dual agonist compounds and uses thereof |
US9012605B2 (en) | 2006-01-23 | 2015-04-21 | Amgen Inc. | Crystalline polypeptides |
EP1986677A2 (en) * | 2006-01-25 | 2008-11-05 | Amgen Inc. | Thrombopoietic compounds |
JO3324B1 (ar) | 2006-04-21 | 2019-03-13 | Amgen Inc | مركبات علاجية مجففة بالتبريد تتعلق بالعصارة الهضمية |
US7981425B2 (en) | 2006-06-19 | 2011-07-19 | Amgen Inc. | Thrombopoietic compounds |
US8173427B2 (en) | 2006-07-24 | 2012-05-08 | The University Of Queensland | Method of producing a population of post-mitotic cells of the neutrophil lineage |
JP2010520855A (ja) | 2007-01-31 | 2010-06-17 | アフィーマックス・インコーポレイテッド | 修飾基をポリペプチドおよびその他の高分子に結合するための窒素ベースのリンカー |
EP2738257A1 (en) | 2007-05-22 | 2014-06-04 | Amgen Inc. | Compositions and methods for producing bioactive fusion proteins |
WO2008157824A2 (en) * | 2007-06-21 | 2008-12-24 | Conjuchem Biotechnologies Inc. | Thrombopoietin peptide conjugates |
US20110097318A1 (en) * | 2007-08-31 | 2011-04-28 | Amgen Inc. | Solid-State Protein Formulation |
US8383114B2 (en) | 2007-09-27 | 2013-02-26 | Amgen Inc. | Pharmaceutical formulations |
WO2009064838A1 (en) | 2007-11-15 | 2009-05-22 | Amgen, Inc. | Aqueous formulation of erythropoiesis stimulating protein stablised by antioxidants for parenteral administration |
ES2559634T3 (es) | 2007-11-28 | 2016-02-15 | Enkam Pharmaceuticals A/S | Péptidos derivados de NCAM (FGLs) |
CA2755336C (en) | 2009-03-20 | 2015-07-14 | Amgen Inc. | Carrier immunoglobulins and uses thereof |
KR101431318B1 (ko) | 2009-04-02 | 2014-08-20 | 로슈 글리카트 아게 | 전장 항체 및 단일쇄 fab 단편을 포함하는 다중특이성 항체 |
NZ598962A (en) | 2009-09-16 | 2014-12-24 | Genentech Inc | Coiled coil and/or tether containing protein complexes and uses thereof |
US20120253009A1 (en) * | 2009-10-16 | 2012-10-04 | Amgen Inc. | Thrombopoietic compounds |
US9662271B2 (en) | 2009-10-23 | 2017-05-30 | Amgen Inc. | Vial adapter and system |
WO2011098095A1 (en) | 2010-02-09 | 2011-08-18 | Aplagen Gmbh | Peptides binding the tpo receptor |
TW201138821A (en) | 2010-03-26 | 2011-11-16 | Roche Glycart Ag | Bispecific antibodies |
TW201742925A (zh) | 2010-04-23 | 2017-12-16 | 建南德克公司 | 異多聚體蛋白質之製造 |
SI2575935T2 (sl) | 2010-06-07 | 2023-12-29 | Amgen Inc. | Naprava za dajanje zdravila |
BR112013003279A2 (pt) | 2010-08-13 | 2016-06-14 | Genentech In | “métodos para tratar uma doença, método para neutralizar ou bloquear a atividade de il-1ß e/ou il-18, anticorpo, usos de um anticorpo e usos de um anticorpo monoclonal” |
KR101586128B1 (ko) | 2010-08-24 | 2016-01-15 | 에프. 호프만-라 로슈 아게 | 디술피드 안정화 ― Fv 단편을 포함하는 이중특이적 항체 |
EA201370076A1 (ru) | 2010-09-22 | 2013-08-30 | Амген Инк. | Иммуноглобулины-переносчики и их применение |
EP2655413B1 (en) | 2010-12-23 | 2019-01-16 | F.Hoffmann-La Roche Ag | Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery |
EP2670776B1 (en) | 2011-02-04 | 2018-11-21 | F. Hoffmann-La Roche AG | Fc VARIANTS AND METHODS FOR THEIR PRODUCTION |
US10689447B2 (en) | 2011-02-04 | 2020-06-23 | Genentech, Inc. | Fc variants and methods for their production |
AU2012236573B2 (en) | 2011-03-31 | 2016-06-02 | Amgen Inc. | Vial adapter and system |
HUE042822T2 (hu) | 2011-04-20 | 2019-07-29 | Amgen Inc | Automata befecskendezõ szerkezet |
RU2654567C2 (ru) | 2011-10-11 | 2018-05-21 | Дженентек, Инк. | Улучшенная сборка биспецифических антител |
IL301153B2 (en) | 2011-10-14 | 2024-05-01 | Amgen Inc | Syringe and assembly method |
WO2013119966A2 (en) | 2012-02-10 | 2013-08-15 | Genentech, Inc. | Single-chain antibodies and other heteromultimers |
CN102552184A (zh) * | 2012-02-16 | 2012-07-11 | 山东泉港药业有限公司 | 一种血小板生成素拟肽冻干制剂 |
MX2014014804A (es) | 2012-06-27 | 2015-02-12 | Hoffmann La Roche | Metodo para la elaboracion de conjugados de la region fc de anticuerpos que comprenden por lo menos una entidad de union que se une especificamente a un objetivo y usos del mismo. |
WO2014001324A1 (en) | 2012-06-27 | 2014-01-03 | Hoffmann-La Roche Ag | Method for selection and production of tailor-made highly selective and multi-specific targeting entities containing at least two different binding entities and uses thereof |
CA3206182A1 (en) | 2012-11-21 | 2014-05-30 | Amgen Inc. | Drug delivery device including insertion member and reservoir |
CN104046642B (zh) * | 2013-03-15 | 2018-07-06 | 兰州大学 | 发酵生产二聚体化融合蛋白的方法 |
CN104045715B (zh) * | 2013-03-15 | 2018-05-01 | 兰州大学 | 二聚体化融合蛋白的制备及应用 |
JP6336564B2 (ja) | 2013-03-15 | 2018-06-06 | アムゲン・インコーポレーテッド | 薬物カセット、自動注入器、および自動注入器システム |
EP2968775B1 (en) | 2013-03-15 | 2019-12-18 | Amgen Inc. | Drug cassette, autoinjector, and autoinjector system |
IL292270B2 (en) | 2013-03-22 | 2024-04-01 | Amgen Inc | Injector and assembly method |
MX2016005312A (es) | 2013-10-24 | 2016-08-11 | Amgen Inc | Inyector y metodo de montaje. |
EP3501575B1 (en) | 2013-10-24 | 2021-12-01 | Amgen Inc. | Drug delivery system with temperature-sensitive-control |
US10994112B2 (en) | 2014-02-05 | 2021-05-04 | Amgen Inc. | Drug delivery system with electromagnetic field generator |
CN105017408B (zh) * | 2014-04-30 | 2019-11-05 | 重庆派金生物科技有限公司 | 聚乙二醇化血小板生成素模拟肽同源四聚体及其用途 |
ES2955736T3 (es) | 2014-05-06 | 2023-12-05 | Hoffmann La Roche | Producción de proteínas heteromultiméricas usando células de mamífero |
EP3785749A1 (en) | 2014-05-07 | 2021-03-03 | Amgen Inc. | Autoinjector with shock reducing elements |
CN106470717B (zh) | 2014-06-03 | 2020-09-11 | 安姆根有限公司 | 药物递送系统和使用方法 |
WO2015199039A1 (ja) * | 2014-06-23 | 2015-12-30 | 東亞合成株式会社 | 細胞の多核化を誘導するペプチドおよびその利用 |
TN2017000109A1 (en) * | 2014-09-26 | 2018-07-04 | Bayer Pharma AG | Stabilized adrenomedullin derivatives and use thereof |
EP3943135A3 (en) | 2014-10-14 | 2022-06-29 | Amgen Inc. | Drug injection device with visual and audible indicators |
CN107001482B (zh) | 2014-12-03 | 2021-06-15 | 豪夫迈·罗氏有限公司 | 多特异性抗体 |
EP3848072A1 (en) | 2014-12-19 | 2021-07-14 | Amgen Inc. | Drug delivery device with proximity sensor |
US11357916B2 (en) | 2014-12-19 | 2022-06-14 | Amgen Inc. | Drug delivery device with live button or user interface field |
JP6730705B2 (ja) * | 2015-02-12 | 2020-07-29 | 国立大学法人岩手大学 | 哺乳動物細胞に対する外来遺伝子の導入効率の向上剤 |
CA2976935C (en) | 2015-02-17 | 2020-03-10 | Amgen Inc. | Drug delivery device with vacuum assisted securement and/or feedback |
JP2018512184A (ja) | 2015-02-27 | 2018-05-17 | アムジエン・インコーポレーテツド | 針ガードの移動に対する抵抗力の閾値が調整可能な針ガード機構を備えた薬物送達装置 |
WO2017039786A1 (en) | 2015-09-02 | 2017-03-09 | Amgen Inc. | Syringe assembly adapter for a syringe |
JP7082568B2 (ja) | 2015-12-09 | 2022-06-08 | アムジエン・インコーポレーテツド | 信号伝達キャップ付き自動注射器 |
WO2017120178A1 (en) | 2016-01-06 | 2017-07-13 | Amgen Inc. | Auto-injector with signaling electronics |
US11200298B2 (en) | 2016-03-15 | 2021-12-14 | Amgen Inc. | Reducing probability of glass breakage in drug delivery devices |
US11541168B2 (en) | 2016-04-29 | 2023-01-03 | Amgen Inc. | Drug delivery device with messaging label |
WO2017192287A1 (en) | 2016-05-02 | 2017-11-09 | Amgen Inc. | Syringe adapter and guide for filling an on-body injector |
CA3018426A1 (en) | 2016-05-13 | 2017-11-16 | Amgen Inc. | Vial sleeve assembly |
US11238150B2 (en) | 2016-05-16 | 2022-02-01 | Amgen Inc. | Data encryption in medical devices with limited computational capability |
WO2017209899A1 (en) | 2016-06-03 | 2017-12-07 | Amgen Inc. | Impact testing apparatuses and methods for drug delivery devices |
US11285266B2 (en) | 2016-07-01 | 2022-03-29 | Amgen Inc. | Drug delivery device having minimized risk of component fracture upon impact events |
WO2018034784A1 (en) | 2016-08-17 | 2018-02-22 | Amgen Inc. | Drug delivery device with placement detection |
US20200261643A1 (en) | 2016-10-25 | 2020-08-20 | Amgen Inc. | On-body injector |
CN108264547B (zh) * | 2016-12-30 | 2021-09-21 | 四川科伦博泰生物医药股份有限公司 | 一种纯化蛋白的方法以及试剂盒 |
MX2019008432A (es) | 2017-01-17 | 2019-11-18 | Amgen Inc | Dispositivos de inyeccion y metodos relacionados de uso y ensamblaje. |
AU2018221351B2 (en) | 2017-02-17 | 2023-02-23 | Amgen Inc. | Insertion mechanism for drug delivery device |
EP3582825A1 (en) | 2017-02-17 | 2019-12-25 | Amgen Inc. | Drug delivery device with sterile fluid flowpath and related method of assembly |
JP2020508803A (ja) | 2017-03-06 | 2020-03-26 | アムジエン・インコーポレーテツド | 作動防止特徴部を備える薬物送達デバイス |
EP3592402A1 (en) | 2017-03-07 | 2020-01-15 | Amgen Inc. | Needle insertion by overpressure |
AU2018230486B2 (en) | 2017-03-09 | 2023-05-11 | Amgen Inc. | Insertion mechanism for drug delivery device |
KR102517342B1 (ko) | 2017-03-28 | 2023-03-31 | 암겐 인코포레이티드 | 플런저 로드 및 주사기 조립 시스템 및 방법 |
US11590294B2 (en) | 2017-06-08 | 2023-02-28 | Amgen Inc. | Syringe assembly for a drug delivery device and method of assembly |
JP7200134B2 (ja) | 2017-06-08 | 2023-01-06 | アムジエン・インコーポレーテツド | トルク駆動式薬物送達デバイス |
EP3641857A1 (en) | 2017-06-22 | 2020-04-29 | Amgen Inc. | Device activation impact/shock reduction |
US11395880B2 (en) | 2017-06-23 | 2022-07-26 | Amgen Inc. | Electronic drug delivery device |
WO2019014014A1 (en) | 2017-07-14 | 2019-01-17 | Amgen Inc. | NEEDLE INSERTION-RETRACTING SYSTEM HAVING DOUBLE TORSION SPRING SYSTEM |
IL271173B2 (en) | 2017-07-21 | 2024-04-01 | Amgen Inc | Gas permeable sealing element for drug container and methods of assembly |
JP2020528296A (ja) | 2017-07-25 | 2020-09-24 | アムジエン・インコーポレーテツド | ギヤモジュールを有する薬物送達デバイス及び関連する組立方法 |
EP3658206A1 (en) | 2017-07-25 | 2020-06-03 | Amgen Inc. | Drug delivery device with container access system and related method of assembly |
WO2019032482A2 (en) | 2017-08-09 | 2019-02-14 | Amgen Inc. | HYDRAULIC-PNEUMATIC PRESSURE CHAMBER DELIVERY SYSTEM |
WO2019036181A1 (en) | 2017-08-18 | 2019-02-21 | Amgen Inc. | BODY INJECTOR WITH STERILE ADHESIVE PATCH |
US11103636B2 (en) | 2017-08-22 | 2021-08-31 | Amgen Inc. | Needle insertion mechanism for drug delivery device |
US11759565B2 (en) | 2017-10-04 | 2023-09-19 | Amgen Inc. | Flow adapter for drug delivery device |
EP3691716B1 (en) | 2017-10-06 | 2023-11-29 | Amgen Inc. | Drug delivery device with interlock assembly and related method of assembly |
EP3694578A1 (en) | 2017-10-09 | 2020-08-19 | Amgen Inc. | Drug delivery device with drive assembly and related method of assembly |
EP3703779A1 (en) | 2017-11-03 | 2020-09-09 | Amgen Inc. | Systems and approaches for sterilizing a drug delivery device |
EP3706830B1 (en) | 2017-11-06 | 2024-08-07 | Amgen Inc. | Drug delivery device with placement and flow sensing |
EP3707075A1 (en) | 2017-11-06 | 2020-09-16 | Amgen Inc. | Fill-finish assemblies and related methods |
JP7247174B2 (ja) | 2017-11-10 | 2023-03-28 | アムジエン・インコーポレーテツド | 薬物送達デバイスのプランジャ |
MA50903A (fr) | 2017-11-16 | 2021-05-12 | Amgen Inc | Auto-injecteur avec détection de décrochage et de point d'extrémité |
CA3079540A1 (en) | 2017-11-16 | 2019-05-23 | Amgen Inc. | Door latch mechanism for drug delivery device |
US10835685B2 (en) | 2018-05-30 | 2020-11-17 | Amgen Inc. | Thermal spring release mechanism for a drug delivery device |
US11083840B2 (en) | 2018-06-01 | 2021-08-10 | Amgen Inc. | Modular fluid path assemblies for drug delivery devices |
EP3586860A1 (en) * | 2018-06-22 | 2020-01-01 | Universität Ulm | Complement inhibitors and uses thereof |
WO2020023336A1 (en) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Hybrid drug delivery devices with grip portion |
MX2021000748A (es) | 2018-07-24 | 2021-03-26 | Amgen Inc | Dispositivos de suministro para administrar farmacos. |
EP3826699A1 (en) | 2018-07-24 | 2021-06-02 | Amgen Inc. | Delivery devices for administering drugs |
WO2020023220A1 (en) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Hybrid drug delivery devices with tacky skin attachment portion and related method of preparation |
MA53320A (fr) | 2018-07-31 | 2021-11-03 | Amgen Inc | Ensemble de trajet de fluide pour dispositif d'administration de médicament |
US20210346601A1 (en) | 2018-09-24 | 2021-11-11 | Amgen Inc. | Interventional dosing systems and methods |
US12042642B2 (en) | 2018-09-28 | 2024-07-23 | Amgen Inc. | Muscle wire escapement activation assembly for a drug delivery device |
TW202027806A (zh) | 2018-10-02 | 2020-08-01 | 美商安進公司 | 具有內部力傳遞的用於藥物遞送之注射系統 |
MX2021003491A (es) | 2018-10-05 | 2021-06-18 | Amgen Inc | Dispositivo de administracion de farmacos con indicador de dosis. |
MX2021004219A (es) | 2018-10-15 | 2021-05-27 | Amgen Inc | Dispositivo de administracion de farmacos con mecanismo de amortiguacion. |
CN112689523A (zh) | 2018-10-15 | 2021-04-20 | 安进公司 | 用于药物递送装置的平台组装方法 |
BR112021007710A2 (pt) | 2018-10-26 | 2021-08-10 | Kyowa Kirin Co., Ltd. | composição farmacêutica para tratar anemia aplástica |
AU2019370159A1 (en) | 2018-11-01 | 2021-04-22 | Amgen Inc. | Drug delivery devices with partial drug delivery member retraction |
TWI831847B (zh) | 2018-11-01 | 2024-02-11 | 美商安進公司 | 部分針頭縮回之藥物遞送裝置及其操作方法 |
US11213620B2 (en) | 2018-11-01 | 2022-01-04 | Amgen Inc. | Drug delivery devices with partial drug delivery member retraction |
JP7510952B2 (ja) | 2019-04-24 | 2024-07-04 | アムジエン・インコーポレーテツド | シリンジ滅菌確認アセンブリ及び方法 |
JP2022545227A (ja) | 2019-08-23 | 2022-10-26 | アムジエン・インコーポレーテツド | 構成可能な針シールド係合構成要素を備えた薬物送達デバイス及び関連方法 |
WO2022129460A1 (en) | 2020-12-18 | 2022-06-23 | Richter Gedeon Nyrt. | Methods for the purification of refolded fc-peptide fusion protein |
CN113402614A (zh) * | 2021-04-22 | 2021-09-17 | 山东泉港药业有限公司 | 血小板生成素拟肽融合蛋白(fc-tmp)编码基因与应用 |
WO2022246055A1 (en) | 2021-05-21 | 2022-11-24 | Amgen Inc. | Method of optimizing a filling recipe for a drug container |
WO2023044774A1 (en) * | 2021-09-24 | 2023-03-30 | Sichuan Clover Biopharmaceuticals, Inc. | Tpo mimetic fusion proteins and methods of use submission of sequence listing as ascii text file |
AU2023241233A1 (en) | 2022-03-24 | 2024-08-15 | Richter Gedeon Nyrt. | Method for the manufacture of biopharmaceuticals |
WO2024036324A1 (en) | 2022-08-11 | 2024-02-15 | Selecta Biosciences, Inc. | Compositions and methods related to immunoglobulin proteases and fusions thereof |
CN117986346B (zh) * | 2024-04-07 | 2024-07-26 | 中国人民解放军军事科学院军事医学研究院 | 一种tpo模拟肽及其应用 |
Family Cites Families (179)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7012859A (pl) * | 1969-09-01 | 1971-03-03 | ||
US3691016A (en) | 1970-04-17 | 1972-09-12 | Monsanto Co | Process for the preparation of insoluble enzymes |
CA1023287A (en) | 1972-12-08 | 1977-12-27 | Boehringer Mannheim G.M.B.H. | Process for the preparation of carrier-bound proteins |
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US3941763A (en) | 1975-03-28 | 1976-03-02 | American Home Products Corporation | PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2 and intermediates |
US4002531A (en) | 1976-01-22 | 1977-01-11 | Pierce Chemical Company | Modifying enzymes with polyethylene glycol and product produced thereby |
US4195128A (en) | 1976-05-03 | 1980-03-25 | Bayer Aktiengesellschaft | Polymeric carrier bound ligands |
US4330440A (en) | 1977-02-08 | 1982-05-18 | Development Finance Corporation Of New Zealand | Activated matrix and method of activation |
CA1093991A (en) | 1977-02-17 | 1981-01-20 | Hideo Hirohara | Enzyme immobilization with pullulan gel |
US4229537A (en) | 1978-02-09 | 1980-10-21 | New York University | Preparation of trichloro-s-triazine activated supports for coupling ligands |
US4289872A (en) | 1979-04-06 | 1981-09-15 | Allied Corporation | Macromolecular highly branched homogeneous compound based on lysine units |
JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
US4503235A (en) | 1983-03-11 | 1985-03-05 | Warner-Lambert Company | Process for producing 4-carbamoyl-1H-imidazolium-5-olate |
US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
EP0154316B1 (en) | 1984-03-06 | 1989-09-13 | Takeda Chemical Industries, Ltd. | Chemically modified lymphokine and production thereof |
EP0173494A3 (en) | 1984-08-27 | 1987-11-25 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric receptors by dna splicing and expression |
EP0206448B1 (en) | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hemoglobin combined with a poly(alkylene oxide) |
US5017691A (en) * | 1986-07-03 | 1991-05-21 | Schering Corporation | Mammalian interleukin-4 |
US5985599A (en) | 1986-05-29 | 1999-11-16 | The Austin Research Institute | FC receptor for immunoglobulin |
US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
AU610083B2 (en) | 1986-08-18 | 1991-05-16 | Clinical Technologies Associates, Inc. | Delivery systems for pharmacological agents |
US5229490A (en) | 1987-05-06 | 1993-07-20 | The Rockefeller University | Multiple antigen peptide system |
US5336603A (en) | 1987-10-02 | 1994-08-09 | Genentech, Inc. | CD4 adheson variants |
ATE106249T1 (de) | 1987-11-05 | 1994-06-15 | Hybritech Inc | Polysaccharidmodifizierte immunglobuline mit reduziertem immunogenem potential oder verbesserter pharmakokinetik. |
US4904584A (en) | 1987-12-23 | 1990-02-27 | Genetics Institute, Inc. | Site-specific homogeneous modification of polypeptides |
DE68926888T2 (de) | 1988-01-22 | 1997-01-09 | Zymogenetics Inc | Verfahren zur Herstellung von sekretierten Rezeptoranalogen |
CA1340810C (en) | 1988-03-31 | 1999-11-02 | Motoo Yamasaki | Polypeptide derivatives of human granulocyte colony stimulating factor |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
GB8824591D0 (en) | 1988-10-20 | 1988-11-23 | Royal Free Hosp School Med | Fractionation process |
CA2006596C (en) | 1988-12-22 | 2000-09-05 | Rika Ishikawa | Chemically-modified g-csf |
EP0452364B1 (en) | 1988-12-22 | 2002-05-22 | Genentech, Inc. | Method for preparing water soluble polypeptides |
US4902502A (en) | 1989-01-23 | 1990-02-20 | Cetus Corporation | Preparation of a polymer/interleukin-2 conjugate |
US5089261A (en) | 1989-01-23 | 1992-02-18 | Cetus Corporation | Preparation of a polymer/interleukin-2 conjugate |
US5098833A (en) | 1989-02-23 | 1992-03-24 | Genentech, Inc. | DNA sequence encoding a functional domain of a lymphocyte homing receptor |
US5225538A (en) | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
US5216131A (en) | 1989-02-23 | 1993-06-01 | Genentech, Inc. | Lymphocyte homing receptors |
US5116964A (en) | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
US5627262A (en) | 1989-07-05 | 1997-05-06 | The Board Of Regents Of The University Of Oklahoma | Method and composition for the treatment of septic shock |
EP0417563B1 (de) | 1989-09-12 | 2000-07-05 | F. Hoffmann-La Roche Ag | TNF-bindende Proteine |
US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
JPH04218000A (ja) | 1990-02-13 | 1992-08-07 | Kirin Amgen Inc | 修飾ポリペプチド |
US5723286A (en) | 1990-06-20 | 1998-03-03 | Affymax Technologies N.V. | Peptide library and screening systems |
CA2109602C (en) | 1990-07-10 | 2002-10-01 | Gregory P. Winter | Methods for producing members of specific binding pairs |
ATE224911T1 (de) | 1990-07-17 | 2002-10-15 | Univ Oklahoma | Gmp-140 ligand |
IE912365A1 (en) | 1990-07-23 | 1992-01-29 | Zeneca Ltd | Continuous release pharmaceutical compositions |
US5252714A (en) | 1990-11-28 | 1993-10-12 | The University Of Alabama In Huntsville | Preparation and use of polyethylene glycol propionaldehyde |
NZ241954A (en) | 1991-03-15 | 1994-01-26 | Amgen Inc | Compositions of g-csf for pulmonary administration. |
CA2106079C (en) | 1991-03-15 | 2000-04-25 | Robert C. Thompson | Pegylation of polypeptides |
US5595732A (en) | 1991-03-25 | 1997-01-21 | Hoffmann-La Roche Inc. | Polyethylene-protein conjugates |
US6139843A (en) | 1991-04-02 | 2000-10-31 | Albert Einstein College Of Medicine Of Yeshiva University | Peptide compositions for the treatment of HIV |
US5281698A (en) | 1991-07-23 | 1994-01-25 | Cetus Oncology Corporation | Preparation of an activated polymer ester for protein conjugation |
US5362852A (en) | 1991-09-27 | 1994-11-08 | Pfizer Inc. | Modified peptide derivatives conjugated at 2-hydroxyethylamine moieties |
US5270170A (en) | 1991-10-16 | 1993-12-14 | Affymax Technologies N.V. | Peptide library and screening method |
US5733731A (en) | 1991-10-16 | 1998-03-31 | Affymax Technologies N.V. | Peptide library and screening method |
NZ244778A (en) | 1991-10-21 | 1994-03-25 | Ortho Pharma Corp | Peg imidates and protein derivatives thereof |
DK0667901T4 (da) * | 1991-10-25 | 2008-11-10 | Immunex Corp | Hidtil ukendt cytokin |
US5376367A (en) | 1991-11-22 | 1994-12-27 | Immunex Corporation | Fusion proteins comprising MGF and IL-3 |
WO1993021259A1 (en) | 1992-04-14 | 1993-10-28 | Cornell Research Foundation Inc. | Dendritic based macromolecules and method of production |
WO1993024135A1 (en) | 1992-05-26 | 1993-12-09 | Immunex Corporation | Novel cytokine that binds cd30 |
US5792451A (en) | 1994-03-02 | 1998-08-11 | Emisphere Technologies, Inc. | Oral drug delivery compositions and methods |
EP0671926B1 (en) | 1992-08-11 | 2002-11-13 | President And Fellows Of Harvard College | Immunomodulatory peptides |
US5844094A (en) * | 1992-09-25 | 1998-12-01 | Commonwealth Scientific And Industrial Research Organization | Target binding polypeptide |
GB9225448D0 (en) | 1992-12-04 | 1993-01-27 | Erba Carlo Spa | Improved synthesis of polymer bioactive conjugates |
NZ247231A (en) * | 1993-03-23 | 1994-10-26 | Holyoake Ind Ltd | Diffuser for air conditioning system; outlet air direction thermostatically controlled |
WO1995009917A1 (en) | 1993-10-07 | 1995-04-13 | The Regents Of The University Of California | Genetically engineered bispecific tetravalent antibodies |
US5922545A (en) | 1993-10-29 | 1999-07-13 | Affymax Technologies N.V. | In vitro peptide and antibody display libraries |
US5773569A (en) | 1993-11-19 | 1998-06-30 | Affymax Technologies N.V. | Compounds and peptides that bind to the erythropoietin receptor |
US5981478A (en) | 1993-11-24 | 1999-11-09 | La Jolla Cancer Research Foundation | Integrin-binding peptides |
GB2285446B (en) | 1994-01-03 | 1999-07-28 | Genentech Inc | Thrombopoietin |
US5608035A (en) | 1994-02-02 | 1997-03-04 | Affymax Technologies N.V. | Peptides and compounds that bind to the IL-1 receptor |
US5880096A (en) | 1994-02-02 | 1999-03-09 | Affymax Technologies N.V. | Peptides and compounds that bind to the IL-1 receptor |
US5786331A (en) | 1994-02-02 | 1998-07-28 | Affymax Technologies N.V. | Peptides and compounds that bind to the IL-1 receptor |
EP0695355A1 (en) * | 1994-02-14 | 1996-02-07 | Kirin Brewery Company, Ltd. | Protein having tpo activity |
CA2183266A1 (en) | 1994-02-14 | 1995-08-17 | Richard D. Holly | Hematopoietic protein and materials and methods for making it |
WO1995021919A2 (en) | 1994-02-14 | 1995-08-17 | Kirin Brewery Company, Limited | Protein having tpo activity |
US5795569A (en) * | 1994-03-31 | 1998-08-18 | Amgen Inc. | Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation |
DK0690127T3 (da) | 1994-03-31 | 1999-05-03 | Amgen Inc | Sammensætninger og fremgangsmåder til stimulering af megakaryocytvækst og -differentiering |
US6309853B1 (en) | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
IL111196A0 (en) | 1994-10-07 | 1994-12-29 | Yeda Res & Dev | Peptides and pharmaceutical compositions comprising them |
US5824784A (en) | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
AU693478B2 (en) | 1994-11-10 | 1998-07-02 | Metabolic Pharmaceuticals Limited | Treatment of obesity |
IL116026A (en) | 1994-11-22 | 2005-08-31 | Rhone Poulenc Rorer Sa | Peptides capable of linking to the sh3 domain of gap, nucleotide sequences encoding the same, their preparation and uses |
JP3511321B2 (ja) * | 1994-11-29 | 2004-03-29 | 出光興産株式会社 | スチレン系重合体の分子量制御方法 |
US5641655A (en) * | 1994-11-30 | 1997-06-24 | Zymogenetics, Inc. | Methods for producing thrombopoietin polypeptides using a mammalian tissue plasminogen activator secretory peptide |
CA2206848A1 (en) | 1994-12-07 | 1996-06-13 | Bionebraska, Inc. | Production of peptides using recombinant fusion protein constructs |
JPH11501506A (ja) | 1994-12-12 | 1999-02-09 | ベス イスラエル デアコネス メディカル センター | キメラ型サイトカインおよびその利用 |
US5888763A (en) | 1994-12-30 | 1999-03-30 | The Rockefeller University | Peptides specific for the first Crk-SH3 domain |
WO1996023899A1 (en) | 1995-02-01 | 1996-08-08 | University Of Massachusetts Medical Center | Methods of selecting a random peptide that binds to a target protein |
IL113159A0 (en) | 1995-03-28 | 1995-06-29 | Yeda Res & Dev | Synthetic peptides and pharmaceutical compositions comprising them |
US5739277A (en) | 1995-04-14 | 1998-04-14 | Genentech Inc. | Altered polypeptides with increased half-life |
US6096871A (en) | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
YU34196A (sh) * | 1995-06-07 | 1999-03-04 | Glaxo Group Limited | Peptidi i jedinjenja koja se vezuju za receptor |
US5767078A (en) | 1995-06-07 | 1998-06-16 | Johnson; Dana L. | Agonist peptide dimers |
EP0885242B1 (en) | 1995-06-07 | 2008-03-26 | Glaxo Group Limited | Peptides and compounds that bind to a thrombopoietin receptor |
US6251864B1 (en) * | 1995-06-07 | 2001-06-26 | Glaxo Group Limited | Peptides and compounds that bind to a receptor |
US5869451A (en) * | 1995-06-07 | 1999-02-09 | Glaxo Group Limited | Peptides and compounds that bind to a receptor |
IL118524A (en) | 1995-06-19 | 2004-02-19 | Akzo Nobel Nv | Peptides and pharmaceutical preparations containing them useful in the treatment of peptide tolerance |
CN102416176A (zh) | 1995-07-27 | 2012-04-18 | 基因技术股份有限公司 | 稳定等渗的冻干蛋白质制剂 |
US5746516A (en) | 1995-08-11 | 1998-05-05 | Hitachi Powdered Metals Co., Ltd. | Porous bearing system having internal grooves and electric motor provided with the same |
WO1997008553A1 (en) | 1995-08-22 | 1997-03-06 | The Regents Of The University Of California | Targeting of proteins to the cell wall of gram-positive bacteria |
US5817750A (en) | 1995-08-28 | 1998-10-06 | La Jolla Cancer Research Foundation | Structural mimics of RGD-binding sites |
JPH09151200A (ja) | 1995-09-29 | 1997-06-10 | Ajinomoto Co Inc | ヒト胃癌に対する免疫応答を誘導できるペプチド及び該ペプチドを含むヒト胃癌治療、予防剤 |
US5670110A (en) | 1995-12-21 | 1997-09-23 | The Procter & Gamble Company | Method for making three-dimensional macroscopically-expanded webs having improved functional surfaces |
US6369027B1 (en) | 1995-12-22 | 2002-04-09 | Amgen Inc. | Osteoprotegerin |
CN1154971A (zh) * | 1996-01-19 | 1997-07-23 | 北京医科大学 | 血小板生长因子(tpo)及其制备方法和用途 |
US5714577A (en) | 1996-01-26 | 1998-02-03 | University Of Pittsburgh | Antimicrobial peptides |
ES2334726T3 (es) | 1996-02-09 | 2010-03-15 | Amgen Inc. | Composicion que comprende il-1ra como inhibidor de interleucina 1 e hialuronano como polimero de liberacion controlada. |
IL117223A0 (en) | 1996-02-22 | 1996-06-18 | Yeda Res & Dev | Antipathogenic polypeptides and compositions comprising them |
ATE279947T1 (de) | 1996-03-18 | 2004-11-15 | Univ Texas | Immunglobulinähnliche domäne mit erhöhten halbwertszeiten |
EP0906419A2 (en) | 1996-03-28 | 1999-04-07 | Chiron Corporation | Peptide ligands of the urokinase receptor |
IL118003A0 (en) | 1996-04-23 | 1996-08-04 | Yeda Res & Dev | Novel vip fragments and pharmaceutical compositions comprising them |
FR2748028B1 (fr) | 1996-04-30 | 1998-08-14 | Lab Francais Du Fractionnement | Peptides derives du facteur von willebrand et leur utilisation comme anticoagulant |
US6100071A (en) | 1996-05-07 | 2000-08-08 | Genentech, Inc. | Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production |
CA2257108A1 (en) | 1996-06-07 | 1997-12-11 | Takeda Chemical Industries, Ltd. | Novel peptides and production and use thereof |
US6126939A (en) | 1996-09-03 | 2000-10-03 | Yeda Research And Development Co. Ltd. | Anti-inflammatory dipeptide and pharmaceutical composition thereof |
WO1998010795A2 (en) | 1996-09-10 | 1998-03-19 | The Burnham Institute | Tumor homing molecules, conjugates derived therefrom, and methods of using same |
US5932546A (en) | 1996-10-04 | 1999-08-03 | Glaxo Wellcome Inc. | Peptides and compounds that bind to the thrombopoietin receptor |
ATE230850T1 (de) | 1996-10-08 | 2003-01-15 | Bisys B V U | Verfahren und mittel zur auswahl von peptiden und proteinen mit spezifischer affinität zu einem zielmolekül |
JP4771563B2 (ja) | 1996-12-06 | 2011-09-14 | アムジエン・インコーポレーテツド | Il−1媒介疾患を処置するためにil−1インヒビターを使用する組合せ療法 |
EA004790B1 (ru) | 1996-12-20 | 2004-08-26 | Амген Инк. | Композиции на основе слитого белка ов и способы их применения |
KR19980066046A (ko) | 1997-01-18 | 1998-10-15 | 정용훈 | 고역가의 CTLA4-Ig 융합단백질 |
WO1998033812A1 (en) | 1997-02-05 | 1998-08-06 | Brigham And Women's Hospital, Inc. | Mast cell protease peptide inhibitors |
US5863735A (en) | 1997-02-24 | 1999-01-26 | Incyte Pharmaceuticals, Inc. | Human transmembrane 4 superfamily protein |
EP0975754B2 (en) | 1997-04-16 | 2016-01-06 | Amgen Inc., | Osteoprotegerin binding proteins and their receptors |
CN1202862C (zh) | 1997-04-17 | 2005-05-25 | 安姆根有限公司 | 包含具有抗体Fc链的稳定、有活性人OB蛋白的结合物的组合物及方法 |
US6265535B1 (en) | 1997-05-30 | 2001-07-24 | The Trustees Of The University Of Pennsylvania | Peptides and peptide analogues designed from binding sites of tumor necrosis factor receptor superfamily and their uses |
AU743490B2 (en) | 1997-06-06 | 2002-01-24 | Regeneron Pharmaceuticals, Inc. | NTN-2 member of TNF ligand family |
WO1999005302A1 (en) | 1997-07-24 | 1999-02-04 | The Perkin-Elmer Corporation | Conjugates of transporter peptides and nucleic acid analogs, and their use |
US6342220B1 (en) | 1997-08-25 | 2002-01-29 | Genentech, Inc. | Agonist antibodies |
US6238667B1 (en) | 1997-09-19 | 2001-05-29 | Heinz Kohler | Method of affinity cross-linking biologically active immunogenic peptides to antibodies |
AU9790798A (en) | 1997-10-06 | 1999-04-27 | Millennium Pharmaceuticals, Inc. | Signal peptide containing proteins and uses therefor |
JP4439111B2 (ja) | 1997-10-10 | 2010-03-24 | サイトビア インコーポレイテッド | ジペプチドのアポトーシスインヒビターおよびそれらの使用 |
DE69812727D1 (de) | 1997-11-07 | 2003-04-30 | Conjuchem Inc | Opioid-konjugate mit endogenen Trägerproteinen |
WO1999038526A1 (en) | 1998-01-29 | 1999-08-05 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Variant peptide ligands that selectively induce apoptosis |
US6162613A (en) | 1998-02-18 | 2000-12-19 | Vertex Pharmaceuticals, Inc. | Methods for designing inhibitors of serine/threonine-kinases and tyrosine kinases |
JP2002505338A (ja) | 1998-03-05 | 2002-02-19 | カイロン コーポレイション | 生物学的に活性な分子の血清半減期を増加するための方法 |
US6235872B1 (en) | 1998-03-12 | 2001-05-22 | The Burnham Institute | Proapoptotic peptides dependence polypeptides and methods of use |
AU3189299A (en) | 1998-03-20 | 1999-10-11 | Chugai Pharmaceutical Co., Ltd. | Peptide ligands for the erythropoietin receptor |
EP0947524A1 (en) | 1998-03-30 | 1999-10-06 | Upither B.V. | Novel peptides for the treatment of autoimmune diseases |
AU744044B2 (en) | 1998-04-06 | 2002-02-14 | Advanced Immunit, Inc. | Short peptides for treatment of neurological degenerative diseases |
JP2002512982A (ja) | 1998-04-28 | 2002-05-08 | アプライド・リサーチ・システムズ・エイアールエス・ホールディング・ナムローゼ・フェンノートシャップ | Peg−lhrhアナログ複合体 |
EP0972780A1 (en) | 1998-05-18 | 2000-01-19 | Applied Research Systems ARS Holding N.V. | Il-6 antagonist peptides |
ATE267018T1 (de) | 1998-05-21 | 2004-06-15 | Tecnogen Scpa | Verwendung von peptidverbindungen zur behandlung von sle |
AU764277B2 (en) | 1998-05-22 | 2003-08-14 | Abbvie Inc. | Peptide antiangiogenic drugs |
US5932548A (en) | 1998-06-03 | 1999-08-03 | Deghenghi; Romano | Lysine containing peptides for treatment of heart disease |
WO2000001402A1 (en) | 1998-07-02 | 2000-01-13 | Envision Biomedical Consulting | Antiproliferative and antiviral proteins and peptides |
US6168785B1 (en) | 1998-07-16 | 2001-01-02 | Institut Pasteur | Biological applications of new peptides of IL-2 and derivatives and use as therapeutic agents |
US20020142374A1 (en) | 1998-08-17 | 2002-10-03 | Michael Gallo | Generation of modified molecules with increased serum half-lives |
WO2000011028A2 (en) | 1998-08-21 | 2000-03-02 | Yeda Research And Development Co. Ltd. | Anti-inflammatory peptides derived from il-2 and analogues thereof |
US7488590B2 (en) | 1998-10-23 | 2009-02-10 | Amgen Inc. | Modified peptides as therapeutic agents |
MY126795A (en) | 1998-10-23 | 2006-10-31 | Amgen K A Inc | Dimeric thrombopoietic peptide mimetics binding to mp1 receptor and having thrombopoietic activity. |
US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
WO2000047740A2 (en) | 1999-02-12 | 2000-08-17 | Amgen Inc. | Tnf-related proteins |
US6635646B1 (en) | 1999-05-04 | 2003-10-21 | Schering Corporation | Pegylated interferon alfa-CCR5 antagonist combination HIV therapy |
JP2003505020A (ja) | 1999-07-02 | 2003-02-12 | ジェネンテック・インコーポレーテッド | ペプチドリガンドドメイン及び多量体化ドメインを含む融合ペプチド |
US6586398B1 (en) | 2000-04-07 | 2003-07-01 | Amgen, Inc. | Chemically modified novel erythropoietin stimulating protein compositions and methods |
CA2407956A1 (en) | 2000-05-03 | 2001-11-08 | Amgen Inc. | Modified peptides as therapeutic agents |
US7396917B2 (en) | 2000-12-05 | 2008-07-08 | Alexion Pharmaceuticals, Inc. | Rationally designed antibodies |
ES2258558T3 (es) | 2000-12-05 | 2006-09-01 | Alexion Pharmaceuticals, Inc. | Anticuerpos diseñados racionalmente. |
AU2002307062A1 (en) | 2001-04-02 | 2002-10-15 | Purdue Pharma L.P. | Thrombopoietin (tpo) synthebody for stimulation of platelet production |
US7205275B2 (en) | 2001-10-11 | 2007-04-17 | Amgen Inc. | Methods of treatment using specific binding agents of human angiopoietin-2 |
US7332474B2 (en) | 2001-10-11 | 2008-02-19 | Amgen Inc. | Peptides and related compounds having thrombopoietic activity |
US7138370B2 (en) | 2001-10-11 | 2006-11-21 | Amgen Inc. | Specific binding agents of human angiopoietin-2 |
WO2004002417A2 (en) | 2002-06-28 | 2004-01-08 | Centocor, Inc. | Mammalian ch1 deleted mimetibodies, compositions, methods and uses |
US7241733B2 (en) | 2002-06-28 | 2007-07-10 | Centocor, Inc. | Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
US6919426B2 (en) | 2002-09-19 | 2005-07-19 | Amgen Inc. | Peptides and related molecules that modulate nerve growth factor activity |
AU2003291689A1 (en) | 2002-10-31 | 2004-05-25 | Protein Design Labs, Inc. | Stable liquid pharmaceutical formulation of antibodies that are prone to isomerization |
EA009056B1 (ru) | 2002-12-20 | 2007-10-26 | Амген, Инк. | Связывающие агенты, ингибирующие миостатин |
CN1871022B (zh) | 2003-08-28 | 2011-07-06 | 奥索-麦克尼尔药品公司 | 结合血小板生成素受体的肽和化合物 |
EP1773400A2 (en) | 2004-07-08 | 2007-04-18 | Amgen Inc. | Therapeutic peptides |
BRPI0516011A (pt) | 2004-09-24 | 2008-08-19 | Amgen Inc | moléculas fc modificadas |
US8258258B2 (en) | 2005-03-10 | 2012-09-04 | Biontech Ag | Dimeric or multimeric microproteins |
US8008453B2 (en) | 2005-08-12 | 2011-08-30 | Amgen Inc. | Modified Fc molecules |
EP1986677A2 (en) | 2006-01-25 | 2008-11-05 | Amgen Inc. | Thrombopoietic compounds |
JO3324B1 (ar) | 2006-04-21 | 2019-03-13 | Amgen Inc | مركبات علاجية مجففة بالتبريد تتعلق بالعصارة الهضمية |
US7981425B2 (en) | 2006-06-19 | 2011-07-19 | Amgen Inc. | Thrombopoietic compounds |
US8197642B2 (en) * | 2007-07-26 | 2012-06-12 | Nichiha Corporation | Inorganic board and method for manufacturing the same |
US10534898B2 (en) | 2017-01-18 | 2020-01-14 | International Business Machines Corporation | Code identification |
-
1999
- 1999-10-22 MY MYPI99004566A patent/MY126795A/en unknown
- 1999-10-22 DK DK99970998T patent/DK1124961T3/da active
- 1999-10-22 AT AT99970998T patent/ATE348163T1/de active
- 1999-10-22 ME MEP42108 patent/MEP42108A/xx unknown
- 1999-10-22 RS YU24301 patent/RS51237B/sr unknown
- 1999-10-22 SI SI9931072T patent/SI2319928T1/sl unknown
- 1999-10-22 PT PT100116896T patent/PT2319928E/pt unknown
- 1999-10-22 CZ CZ20011287A patent/CZ302155B6/cs not_active IP Right Cessation
- 1999-10-22 CN CNB998125172A patent/CN1250721C/zh not_active Expired - Lifetime
- 1999-10-22 TW TW88118317A patent/TWI250988B/zh not_active IP Right Cessation
- 1999-10-22 US US09/422,838 patent/US6835809B1/en not_active Expired - Lifetime
- 1999-10-22 TW TW94140160A patent/TWI257394B/zh not_active IP Right Cessation
- 1999-10-22 PT PT99970998T patent/PT1124961E/pt unknown
- 1999-10-22 DK DK06022333T patent/DK1783222T3/da active
- 1999-10-22 ES ES99970998T patent/ES2279649T3/es not_active Expired - Lifetime
- 1999-10-22 ME MEP-2008-421A patent/ME00238B/me unknown
- 1999-10-22 SI SI9930953T patent/SI1124961T1/sl unknown
- 1999-10-22 BR BRPI9914698A patent/BRPI9914698B8/pt not_active IP Right Cessation
- 1999-10-22 ES ES06022333T patent/ES2388341T3/es not_active Expired - Lifetime
- 1999-10-22 AR ARP990105333 patent/AR020934A1/es active IP Right Grant
- 1999-10-22 ES ES10011689T patent/ES2422231T3/es not_active Expired - Lifetime
- 1999-10-22 EA EA200100465A patent/EA003998B1/ru not_active IP Right Cessation
- 1999-10-22 SK SK496-2001A patent/SK287737B6/sk not_active IP Right Cessation
- 1999-10-22 IL IL14202399A patent/IL142023A0/xx active Protection Beyond IP Right Term
- 1999-10-22 KR KR1020017004723A patent/KR100719202B1/ko active Protection Beyond IP Right Term
- 1999-10-22 EP EP20100011689 patent/EP2319928B9/en not_active Expired - Lifetime
- 1999-10-22 PL PL348041A patent/PL219605B1/pl unknown
- 1999-10-22 EP EP19990970998 patent/EP1124961B9/en not_active Expired - Lifetime
- 1999-10-22 DK DK10011689T patent/DK2319928T3/da active
- 1999-10-22 AU AU12239/00A patent/AU773891C/en not_active Expired
- 1999-10-22 NZ NZ510529A patent/NZ510529A/en not_active IP Right Cessation
- 1999-10-22 DE DE1999634425 patent/DE69934425T2/de not_active Expired - Lifetime
- 1999-10-22 CA CA 2346996 patent/CA2346996C/en not_active Expired - Lifetime
- 1999-10-22 PT PT06022333T patent/PT1783222E/pt unknown
- 1999-10-22 HU HU0104327A patent/HU228582B1/hu unknown
- 1999-10-22 DE DE200912000039 patent/DE122009000039I1/de active Pending
- 1999-10-22 EP EP20060022333 patent/EP1783222B1/en not_active Expired - Lifetime
- 1999-10-22 WO PCT/US1999/024834 patent/WO2000024770A2/en active IP Right Grant
- 1999-10-22 CN CN2006100044518A patent/CN1810832B/zh not_active Expired - Lifetime
- 1999-10-22 JP JP2000578340A patent/JP3820105B2/ja not_active Expired - Lifetime
- 1999-10-22 SI SI9931068T patent/SI1783222T1/sl unknown
-
2001
- 2001-03-14 ZA ZA200102102A patent/ZA200102102B/en unknown
- 2001-04-03 BG BG11022101A patent/BG110221A/en unknown
- 2001-04-03 BG BG105401A patent/BG65663B1/bg unknown
- 2001-04-20 NO NO20011962A patent/NO331027B1/no not_active IP Right Cessation
-
2002
- 2002-05-27 HK HK02103927.0A patent/HK1042114B/zh not_active IP Right Cessation
-
2004
- 2004-09-02 US US10/933,133 patent/US8044174B2/en not_active Expired - Fee Related
-
2006
- 2006-01-19 US US11/335,878 patent/US9145450B2/en not_active Expired - Lifetime
- 2006-04-10 JP JP2006107321A patent/JP4332163B2/ja not_active Expired - Lifetime
- 2006-12-14 HK HK06113797A patent/HK1093075A1/xx not_active IP Right Cessation
- 2006-12-22 US US11/644,757 patent/US20070142295A1/en not_active Abandoned
-
2007
- 2007-03-12 CY CY20071100334T patent/CY1107526T1/el unknown
-
2008
- 2008-09-16 BG BG10110221A patent/BG66190B1/bg unknown
-
2009
- 2009-03-13 US US12/404,047 patent/US7994117B2/en not_active Expired - Fee Related
- 2009-07-29 LT LTPA2009006C patent/LTC1124961I2/lt unknown
- 2009-07-30 FR FR09C0030C patent/FR09C0030I2/fr active Active
- 2009-07-30 LU LU91598C patent/LU91598I2/fr unknown
- 2009-08-03 CY CY2009012C patent/CY2009012I1/el unknown
- 2009-08-03 NL NL300398C patent/NL300398I2/nl unknown
-
2011
- 2011-10-20 US US13/278,137 patent/US8748571B2/en not_active Expired - Fee Related
-
2012
- 2012-03-12 NO NO2012005C patent/NO2012005I2/no unknown
- 2012-04-27 US US13/458,744 patent/US8618044B2/en not_active Expired - Fee Related
- 2012-09-05 CY CY20121100797T patent/CY1113107T1/el unknown
-
2013
- 2013-06-14 CY CY20131100482T patent/CY1114940T1/el unknown
-
2014
- 2014-04-30 US US14/266,563 patent/US9534032B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO331027B1 (no) | Forbindelse som bindes til en mpl-reseptor, dimer, polynukleotid, vektor, vertscelle, fremgangsmate for fremstilling av en forbindelse, anvendelse av en forbindelse for fremstilling av et medikament, samt farmasoytisk preparat. | |
DK0807111T3 (da) | Substituerede heterocykliske forbindelser, fremgangsmåde til fremstillingen heraf samt farmaceutiske sammensætninger indeholdende disse | |
NO305907B1 (no) | Forbindelser, forbindelser for bekjempelse av sykdommer, legemidler som endotelinreseptorantagonist, farmasöytiske preparater samt anvendelse av slike forbindelser til fremstilling av legemidler | |
DZ3191A1 (fr) | Composés d'indazole et compositions pharmaceutiques inhibant les protéines kinases, et procédés d'utilisation de ceux-ci. | |
NO973923D0 (no) | Nye taxoider, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene | |
BR9810802B1 (pt) | composto, composição farmacêutica, e, processo para a preparação de um composto. | |
DK1042355T3 (da) | 11beta-halogen-7alfa-substituerede estratriener, fremgangsmåde til fremstilling af farmaceutiske præparater, der indeholder disse 11beta-halogen-7alfa-substituerede estratriener, samt deres anvendelse til fremstilling af lægemidler | |
DK0920441T3 (da) | 7alfa-(epsilon-aminoalkyl)-estratriener, fremgangsmåde til deres fremstilling, farmaceutiske præparater, som indeholder disse 7-alfa-(epsilon-aminoalkyl)-estratriener, samt deres anvendelse til fremstilling af lægemidler | |
IT1289160B1 (it) | Compressa farmaceutica completamente rivestita per il rilascio controllato di principi attivi che presentano problemi di | |
NO986023L (no) | Vannbasert, farmas°ytisk preparat | |
TR199800631A3 (tr) | Ecza formülasyonu. | |
NO980273L (no) | Femleddede heterocykluser med bifenylsulfonylsubstitusjon fremgangsmÕte for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen | |
AR028162A1 (es) | Disponibilidad controlada de compuestos de formulacion, composiciones y metodos para el lavado que utilizan los mismos. | |
DK1222163T3 (da) | 2'-Substituerede 1,1'-biphenyl-2-carboxamider, fremgangsmåder til fremstilling deraf, deres anvendelse som medikament samt farmaceutiske præparater, som indeholder dem | |
PT1112266E (pt) | 4-amino-2-aril-pirimidinas substituidas, sua preparacao, sua utilizacao e composicoes farmaceuticas que as contem. | |
NO20003496D0 (no) | Nye aromatiske amider, fremgangsmÕte for fremstilling av disse, samt deres anvendelse som medisiner | |
BR9906373B1 (pt) | compostos pirimidinona, composições farmacêuticas contendo os compostos e processos para a preparação dos mesmos. | |
HK1015789A1 (en) | Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use. | |
HK1040249A1 (en) | Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical composition containing said compounds and the use thereof. | |
DK1140031T3 (da) | Farmaceutisk sammensætning til kontrolleret frigivelse med tilidinmesylat som aktivt stof | |
IT1311921B1 (it) | Composti farmaceutici. | |
NO960364D0 (no) | Basisk-substituerte benzolguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen | |
NO20022801D0 (no) | Substituerte norbornylaminoderivater, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikumsåvel som medikamenter inneholdende disse | |
NO972433L (no) | Substituerte 2-naftoylguanidiner, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene | |
HK1045684A1 (en) | Biphenyl derivatives as antagonists of the neurokinine-1 receptor. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
SPCF | Filing of supplementary protection certificate |
Free format text: PRODUCT NAME: NPLATE (2 FORSKJELLIGE PREPARATVARIANTER); NAT. REG. NO/DATE: EU/1/08/497/001/NO 20090204; FIRST REG. NO/DATE: EU/1/08/497/001/NO 20090204 Spc suppl protection certif: 2012005 Filing date: 20120312 |
|
SPCG | Granted supplementary protection certificate |
Free format text: PRODUCT NAME: NPLATE (2 FORSKJELLIGE PREPARATVARIANTER); NAT. REG. NO/DATE: EU/1/08/497/001/NO 20090204; FIRST REG. NO/DATE: EU/1/08/497/001/NO 20090204 Spc suppl protection certif: 2012005 Filing date: 20120312 Extension date: 20240204 |
|
MK1K | Patent expired | ||
SPCX | Expiry of an spc |
Spc suppl protection certif: 2012015 |